mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.057 |
0.3 |
mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
0.17 |
0.3 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.3 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |